Agenda
Thursday, June 4, 2026
InterContinental SF
12:30 p.m.
Conference Registration & Grab n’ Go Lunch
1:00 – 5:30 p.m.
Partnering Hall
1:00 p.m.
Opening Remarks
Elton Satusky and Andrea Linna, Wilson Sonsini
1:05 – 1:50 p.m.
C-Suite Shaping the Future of Medtech and Digital Health
Moderator:
Andrea Linna, Wilson Sonsini
Speakers:
Sandeep Akkaraju, Exo Imaging
Lyle Berkowitz, KeyCare
Gabriel Jones, Proprio
1:50 – 2:00 p.m.
Break
2:00 – 2:45 p.m.
IP & Patent Strategies for High-Growth Companies
Moderator:
Ali Alemozafar, Wilson Sonsini
Speakers:
Yina Dong, Veracyte
Mark Longo, Sirona Medical
Gabriel Sanchez, Enspectra Health
2:00 – 4:00 p.m.
MTI Alumni Showcase
2:45 – 2:55 p.m.
Break
2:55 – 3:40 p.m.
How AI is Shaping Healthcare
Moderator:
Danielle Naftulin, Wilson Sonsini
Speakers:
Joe Cunningham, Santé Ventures
Amir Dan Rubin, Healthier Capital
Thomas Knox, VitVio
3:40 – 3:50 p.m.
Break
3:50 – 4:35 p.m.
IPO Landscape: Executive Perspectives & Case Studies
Moderator:
Eric Hsu, Wilson Sonsini
Speakers:
John McCutcheon, EBR Systems
Matthew Strom, Morgan Stanley
4:35 – 4:45 p.m.
Break
4:45 – 5:30 p.m.
Strategic Investments in Women’s Health
Moderator:
Lianna Whittleton, Wilson Sonsini
Speakers:
Kara Egan, Teal Health
Nada Hanafi, Medtech Color & Women’s Health Advocates
Maneesh Jain, Mirvie
5:30 – 7:00 p.m.
Opening Reception
Friday, June 5, 2026
InterContinental SF
8:00 – 8:45 a.m.
Rise & Connect: A Women’s Morning at MDC
8:00 – 9:00 a.m.
Conference Registration and Continental Breakfast
9:00 a.m. – 4:00 p.m.
Partnering Hall
9:00 – 9:05 a.m.
Opening Remarks
Alex Key, Rob Parr, Eric Hsu, Wilson Sonsini
9:05 – 9:45 a.m.
Keynote Interview
Stephen Levin, editor-in-chief of MedTech Strategist/Market Pathways, will interview Mark Leahey, president and CEO of the Medical Device Manufacturers Association, on the shifting medtech policy landscape amid the global volatility and uncertainty in Washington.
9:45 – 10:00 a.m.
Break
10:00 – 10:45 a.m.
Medtech & Digital Health by the Numbers
Join Jonathan Norris from HSBC Innovation and Jennie Xue from Goldman Sachs for an upbeat look at the momentum building in medtech and digital health. They will highlight 2025’s strong fundraising and deal activity and share why 2026 is expected to present exciting opportunities for companies to secure venture capital, form strategic partnerships, and successfully enter the public markets.
Speakers:
Jonathan Norris, HSBC Innovation
Jennie Xue, Goldman Sachs
10:45 – 11:00 a.m.
Break
11:00 – 11:45 a.m.
The Evolving Landscape of National Security & Global Trade
As geopolitical concerns increasingly create hurdles for cross-border collaboration in biotechnology, maintaining visibility into evolving national security and trade requirements is critical for effective global partnering. During this session, we’ll discuss how developments ranging from the BIOSECURE Act and new DOJ data export rules to pharmaceutical tariffs and the FCC’s national security controls on hardware importation are impacting the medical device community—and how medical device companies are addressing those challenges.
Speakers:
Sophia Galleher, Wilson Sonsini
Joshua Gruenspecht, Wilson Sonsini
Anne Seymour, Wilson Sonsini
11:45 – 12:00 p.m.
Break
12:00 p.m. – 12:45 p.m.
Navigating AI Risks and Considerations
Moderator:
Rob Parr, Wilson Sonsini
Speakers:
Sean K. Mehra, HealthTap
Jonathan Stevens, Anterior
12:45 – 1:30 p.m.
Lunch
1:30 – 2:15 p.m.
Enhancing Patient Care with Digital Health Platforms
Moderator:
Alex Key, Wilson Sonsini
Speakers:
Leo Petrossian, Kandu, Inc.
Noel Pugh, Lōvu Health
Sameer Jafri, Avive Solutions, Inc.
2:15 – 2:30 p.m.
Break
2:30 – 3:15 p.m.
The State of Medtech Investing: Strategic and Venture Perspectives
This panel brings together leading venture investors and strategic partners to discuss the current state of medtech investing, including where capital is flowing, how investment priorities are evolving, and what differentiates companies that receive funding. Drawing from both venture and corporate perspectives, the discussion will also explore how strategics evaluate partnership and acquisition opportunities, and what it takes for companies to position themselves for long-term success.
Moderator:
Brian Appel, Wilson Sonsini
Speakers:
Tamir Meiri, Johnson & Johnson – JJDC
Tracy Pappas, Treo Ventures
Suchira Sharma, Elevage Medical
3:15 – 3:30 p.m.
Break
3:30 – 4:10 p.m.
Keynote Fireside Chat
Christian Howell, CEO, will discuss the responsibility that comes with hope in neurodegenerative disease, and why innovation must be measured not just by discovery but its ability to deliver durable, real-world impact for patients. Moderated by Mark Fitzgerald, partner at Wilson Sonsini, the discussion will explore how emerging approaches are redefining what meaningful progress looks like in brain health.
